AMRX PDUFA decision: a positive outcome, +8.7%

On June 16, 2020, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +8.7% in the window around the event. It had already run +8.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.